Ireland · Delayed Price · Currency is EUR Ovoca Bio Statistics
Total Valuation
Ovoca Bio has a market cap or net worth of EUR 856,420. The enterprise value is -2.07 million.
| Market Cap | 856,420 |
| Enterprise Value | -2.07M |
Important Dates
The last earnings date was Wednesday, June 25, 2025.
| Earnings Date | Jun 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ovoca Bio has 81.56 million shares outstanding. The number of shares has increased by 6.93% in one year.
| Current Share Class | 81.56M |
| Shares Outstanding | 81.56M |
| Shares Change (YoY) | +6.93% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 36.18% |
| Owned by Institutions (%) | n/a |
| Float | 52.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.38 |
| P/TBV Ratio | 0.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 2.12 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.58 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.59
| Current Ratio | 3.59 |
| Quick Ratio | 3.59 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 266.00 |
Financial Efficiency
Return on equity (ROE) is -108.96% and return on invested capital (ROIC) is 4.56%.
| Return on Equity (ROE) | -108.96% |
| Return on Assets (ROA) | 3.70% |
| Return on Invested Capital (ROIC) | 4.56% |
| Return on Capital Employed (ROCE) | 11.89% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -714,600 |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.53% in the last 52 weeks. The beta is 0.69, so Ovoca Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | +10.53% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 23.17 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | 266,000 |
| Pretax Income | -3.98M |
| Net Income | -3.57M |
| EBITDA | 595,000 |
| EBIT | 266,000 |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 2.93 million in cash and n/a in debt, giving a net cash position of 2.93 million or 0.04 per share.
| Cash & Cash Equivalents | 2.93M |
| Total Debt | n/a |
| Net Cash | 2.93M |
| Net Cash Per Share | 0.04 |
| Equity (Book Value) | 2.24M |
| Book Value Per Share | 0.02 |
| Working Capital | 2.24M |
Cash Flow
| Operating Cash Flow | 404,000 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Ovoca Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.93% |
| Shareholder Yield | n/a |
| Earnings Yield | -417.20% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 18, 2010. It was a reverse split with a ratio of 0.2.
| Last Split Date | Jan 18, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |